| No PTH decrease N = 67 | Spontaneous PTH decrease N = 70 | Medical PTH decrease N = 50 | Surgical PTX N = 10 |
---|---|---|---|---|
Age (years) | 66.8 ± 14 | 71.2 ± 12 | 64.1 ± 16 | 51 ± 15 * |
Female gender (%) | 46.3 | 27.1 * | 53.1 | 40 |
Dialysis vintage (months) | 75.1 ± 98 | 71.5 ± 73 | 53 ± 61 * | 90.5 ± 94 |
Diabetes (%) | 37.3 | 41.4 | 24.5 * | 0 * |
Cardiac disease (%) | 28.4 | 30 | 10 * | 10 * |
Peripheral vascular disease (%) | 27 | 25 | 8 * | 0 * |
Stroke (%) | 9 | 13 | 4 * | 0 * |
Cancer (%) | 7 | 16 | 16.3 | 10 |
BMI (kg/m2) | 25.8 ± 5 | 24.7 ± 5 | 24.6 ± 4 | 25 ± 4 |
Body weight (kg) | 71.1 ± 18 | 69.7 ± 16 | 67.4 ± 13 | 70.5 ± 17 |
Dialysis session time (min) | 330 ± 95 | 322 ± 90 | 327 ± 92 | 410 ± 100 * |
Central catheter (%) | 13.4 | 20 | 12.5 | 10 |
HDF (%) | 40.3 | 40.3 | 39.6 | 12.5 * |
Dialysate calcium (mmol/L) | 1.5 ± 0.16 | 1.47 ± 0.16 | 1.53 ± 0.14 | 1.7 ± 0.18 * |
spKt/V | 2.3 ± 0.7 | 2.1 ± 0.6 | 2.4 ± 0.7 | 2.7 ± 1 * |
nPNA (g/kg/day) | 1.42 ± 0.6 | 1.14 ± 0.2 | 1.3 ± 0.4 | 1.43 ± 0.3 |
PTH (pg/mL) | 198.6 ± 152 | 218 ± 126 | 280 ± 144 | 498 ± 315 * |
Calcaemia (mmol/L) | 2.26 ± 0.14 | 2.23 ± 0.14 | 2.25 ± 0.12 | 2.31 ± 0.12 |
Phosphataemia (mmol/L) | 1.42 ± 0.3 | 1.34 ± 0.36 | 1.36 ± 0.3 | 1.26 ± 0.2 |
b-ALP (μg/L) | 18 ± 10 | 21 ± 15 | 19 ± 11 | 35.6 ± 27 * |
25-OHD (nmol/L) | 106 ± 49 | 112 ± 39 | 104 ± 41 | 120 ± 28 |
Serum Albumin (g/L) | 33.5 ± 4 | 31.1 ± 4 | 33.8 ± 4 | 36.8 ± 3 * |
C-reactive protein (mg/L) | 11.7 ± 16 | 14.6 ± 18 | 7.6 ± 8 | 4.3 ± 3 * |
Cholecalciferol (%) | 90.5 | 92.3 | 93.3 | 90 |
Alfacalcidol % (μg/week) | 10 (2.2) | 10 (1.6) | 25 (2.5) | 50 (2.9) * |
CacCO3 % (g/day) | 27 (1.2) | 16 (1.1) | 30 (2) | 30 (2.4) |
Sevelamer % (g/day) | 39 (1.8) | 21 (1.2) | 37 (1.8) | 20 (2) |
Cinacalcet % (mg/day) | 22 (35) | 7 (30) | 6 (39) | 50 (60) * |